NRBO - NeuroBo says DA-1241 Wegovy combo shows potential in treating MASH
2024-05-22 10:01:06 ET
More on NeuroBo Pharmaceuticals
- NeuroBo Phase 2a study for MASH drug to proceed as planned
- NeuroBo stock jumps 14% on weight-loss drug update
- Seeking Alpha’s Quant Rating on NeuroBo Pharmaceuticals
- Historical earnings data for NeuroBo Pharmaceuticals
- Financial information for NeuroBo Pharmaceuticals